The Efficacy and Safety of Pirfenidone Combined With Immunosuppressant Therapy in Connective Tissue Disease-Associated Interstitial Lung Disease: A 24-Week Prospective Controlled Cohort Study

OBJECTIVE: Interstitial lung disease (ILD) is a common manifestation of connective tissue disease (CTD) that manifests as several subtypes with significant differences in prognosis. It is necessary to evaluate the efficacy and safety of pirfenidone (PFD) combined with immunosuppressant (IS) in the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiaqi, Wang, Xiao, Qi, Xiaoyan, Sun, Zhijian, Zhang, Tao, Cui, Yi, Shu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135161/
https://www.ncbi.nlm.nih.gov/pubmed/35646960
http://dx.doi.org/10.3389/fmed.2022.871861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135161/
https://www.ncbi.nlm.nih.gov/pubmed/35646960
http://dx.doi.org/10.3389/fmed.2022.871861

Ejemplares similares